Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The VP1 hydrophobic pocket of Human Rhinovirus 16 (HRV16) is a specialized cavity located within the VP1 protein of the viral capsid, situated beneath the floor of the “canyon” which serves as the binding site for the host cell receptor ICAM-1 [1][2]. In its native state, this pocket is often occupied by a host-derived “pocket factor,” typically a fatty acid-like molecule, which maintains the structural stability of the virion [2]. During the infection process, the displacement of this pocket factor is a prerequisite for the conformational changes required for viral uncoating and the subsequent release of the viral RNA into the host cytoplasm [1][4]. Therapeutic agents known as capsid binders, such as Pleconaril, target this pocket by binding with higher affinity than the natural pocket factor, thereby over-stabilizing the capsid and preventing the uncoating process [3][5]. This mechanism effectively halts viral replication at the early entry stage, making the VP1 pocket a focal point for antiviral strategies against HRV-mediated respiratory illnesses, including the common cold and exacerbations of asthma or COPD [3][5]. Citations: [1] Rossmann MG, et al. Nature. 1985;317(6033):145-153. [2] Oliveira MA, et al. Structure. 1993;1(1):51-68. [3] Pevear DC, et al. Antimicrob Agents Chemother. 1999;43(9):2109-2115. [4] Ledford RM, et al. J Virol. 2004;78(7):3663-3674. [5] Rotbart HA. Antiviral Res. 2002;53(2):83-98.
Capsid stabilization and inhibition of viral uncoating
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Rhinovirus 16 capsid protein VP1 hydrophobic pocket (HRV16 VP1 pocket).